Document is current
Any future updates will be listed below
-
Authors
Tseng, Hung Fu https://orcid.org/0000-0001-6184-6534
Ackerson, Bradley K. https://orcid.org/0000-0002-0816-7345
Bruxvoort, Katia J. https://orcid.org/0000-0001-8277-2431
Sy, Lina S. https://orcid.org/0000-0003-2762-9266
Tubert, Julia E.
Lee, Gina S. https://orcid.org/0000-0002-7554-9116
Ku, Jennifer H.
Florea, Ana
Luo, Yi https://orcid.org/0000-0001-8990-2470
Qiu, Sijia
Choi, Soon Kyu
Takhar, Harpreet S.
Aragones, Michael
Paila, Yamuna D.
Chavers, Scott
Talarico, Carla A.
Qian, Lei
-
Funding
Funding for this research was provided by:
Moderna, Inc.
- License Information
-
More Information
Article History
Received: 6 October 2022
Accepted: 3 January 2023
First Online: 12 January 2023
Competing interests
: H.F.T., B.K.A., L.S.S., J.E.T., G.S.L., J.H.K., A.F., Y.L., S.Q., S.K.C., H.S.T., M.A., and L.Q. are employees of Kaiser Permanente Southern California, which has been contracted by Moderna to conduct this study. K.J.B. is an adjunct investigator at Kaiser Permanente Southern California. Y.D.P. and S.C. are employees of and shareholders in Moderna, Inc. C.A.T. was an employee of and a shareholder in Moderna, Inc at the time of analysis conception; C.A.T. is currently an employee of AstraZeneca. H.F.T. received funding from GlaxoSmithKline unrelated to this manuscript; H.F.T. also served on advisory boards for Janssen and Pfizer. B.K.A. received funding from GlaxoSmithKline, Dynavax, Genentech, and Pfizer unrelated to this manuscript. K.J.B. received funding from GlaxoSmithKline, Dynavax, Pfizer, and Gilead unrelated to this manuscript. L.S.S. received funding from GlaxoSmithKline and Dynavax unrelated to this manuscript. J.E.T. received funding from Pfizer unrelated to this manuscript. G.S.L. received funding from GlaxoSmithKline unrelated to this manuscript. J.H.K. received funding from GlaxoSmithKline unrelated to this manuscript. A.F. received funding from Pfizer, GlaxoSmithKline, and Gilead unrelated to this manuscript. Y.L. received funding from GlaxoSmithKline and Pfizer unrelated to this manuscript. S.Q. received funding from Dynavax unrelated to this manuscript. S.K.C. received funding from Pfizer and the Pancreatic Cancer Action Network unrelated to this manuscript. HST received funding from GlaxoSmithKline, Pfizer, A.L.K., and Wellcome unrelated to this manuscript. M.A. received funding from Pfizer unrelated to this manuscript. L.Q. received funding from GlaxoSmithKline and Dynavax unrelated to this manuscript.
